Antibe Therapeutics Inc (ATBPF)
0.2156
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Antibe Therapeutics Total Assets (Quarterly): 42.49M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 42.49M |
| September 30, 2023 | 44.29M |
| June 30, 2023 | 50.44M |
| March 31, 2023 | 52.17M |
| December 31, 2022 | 54.32M |
| September 30, 2022 | 57.89M |
| June 30, 2022 | 64.79M |
| March 31, 2022 | 71.41M |
| December 31, 2021 | 72.52M |
| September 30, 2021 | 75.15M |
| June 30, 2021 | 82.95M |
| March 31, 2021 | 64.76M |
| December 31, 2020 | 19.23M |
| September 30, 2020 | 22.22M |
| June 30, 2020 | 28.43M |
| March 31, 2020 | 9.758M |
| December 31, 2019 | 11.65M |
| September 30, 2019 | 13.15M |
| June 30, 2019 | 9.821M |
| March 31, 2019 | 11.10M |
| December 31, 2018 | 9.004M |
| September 30, 2018 | 9.382M |
| Date | Value |
|---|---|
| June 30, 2018 | 9.819M |
| March 31, 2018 | 9.672M |
| December 31, 2017 | 8.222M |
| September 30, 2017 | 9.667M |
| June 30, 2017 | 9.975M |
| March 31, 2017 | 8.043M |
| December 31, 2016 | 8.223M |
| September 30, 2016 | 7.459M |
| June 30, 2016 | 8.203M |
| March 31, 2016 | 7.504M |
| December 31, 2015 | 7.154M |
| September 30, 2015 | 0.6405M |
| June 30, 2015 | 1.240M |
| March 31, 2015 | 0.6226M |
| December 31, 2014 | 1.069M |
| September 30, 2014 | 2.166M |
| June 30, 2014 | 3.204M |
| March 31, 2014 | 3.937M |
| December 31, 2013 | 1.862M |
| September 30, 2013 | 1.781M |
| June 30, 2013 | 1.942M |
| March 31, 2013 | 0.7263M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.758M
Minimum
Mar 2020
82.95M
Maximum
Jun 2021
44.60M
Average
50.44M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| InMed Pharmaceuticals Inc | 13.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 22.93M |
| Shareholders Equity (Quarterly) | 19.55M |